Skip to content
healthcare.dev
Get a free key

INVEGA HAFYERA

NDC 50458-612, paliperidone palmitate, injection, suspension, extended release, from Janssen Pharmaceuticals, Inc.

Product NDC
50458-612
Status
Listed
Labeler
Janssen Pharmaceuticals, Inc
Dosage form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA207946
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50458-612 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALIPERIDONE PALMITATE1560 mg/5mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
50458-612-01504580612011 SYRINGE in 1 CARTON (50458-612-01) / 5 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50458-612

  • NADAC price for package 50458061201

    GET /v1/drugs/nadac/50458061201

Use it

Look up 50458-612 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50458-612 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50458-612. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.